Shares of United Therapeutics UTHR rallied 12.5% on Monday after the company unveiled robust data from the phase III TETON-1 ...

Although no differences were seen in the standardized mean differences for respiratory rate or oxygen saturation when comparing nebulized normal saline with another placebo, a difference in ...

United Therapeutics Corporation Strong Buy: phase 3 Tyvaso wins in IPF boost FVC, support summer sNDA and Priority Review ...

United Therapeutics Corporation UTHR shares are up during Monday’s premarket session following the announcement that the ...

Please provide your email address to receive an email when new articles are posted on . The ICoN-1 trial has been discontinued, and futility was the reason for this decision. The company is still ...

Nebulized amphotericin B does not improve exacerbation-free status at 1 year for patients with bronchopulmonary aspergillosis, though it may delay onset and incidence. Investigators searched PubMed ...

Please provide your email address to receive an email when new articles are posted on . More patients in the ED with hemoptysis saw an end to the condition with nebulized vs. IV tranexamic acid.

United Therapeutics (UTHR) shares ended the last trading session 12.5% higher at $588.36. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the ...

COPD, or chronic obstructive pulmonary disease, is a group of life-changing lung diseases that include emphysema and chronic bronchitis. 1 Those living with COPD can experience coughing, wheezing, ...

Am J Health Syst Pharm. 2006;63(18):1704-1716. The toxicity of nebulized amphotericin B was evaluated in 29 patients suffering from prolonged neutropenia. [42] Amphotericin B 30 mg was diluted in 3 mL ...

COPD, or chronic obstructive pulmonary disease, is a group of life-changing lung diseases that include emphysema and chronic bronchitis. 1 Those living with COPD can experience coughing, wheezing, ...